Orthobiologics

Biomatlante's MBCP+ synthetic bone graft matrix has been selected for comparison to autograft in a 5-year trial in the treatment of...

Heraeus Medical is launching PALACOS® MV medium viscosity bone cement and PALAMIX® and PALABOWL® mixing systems. ...

Collagen Matrix entered the India market with OssiMend® bone graft matrix for spinal applications. ...

Bone Therapeutics finished recruitment of 32 patients in the U.S. Phase IIA study of ALLOB® allogeneic bone-cell therapy in lumbar spinal...

Bone Solutions reached the milestone of 50 successful implants of OsteoCrete® magnesium-based bone void filler....

Orthocell was granted an Australian patent, "Sutureless repair of soft tissue," addressing the CelGro® collagen medical device platform. ...

MiMedx commenced enrollment in a Phase III Investigational New Drug clinical trial of AmnioFix® Injectable in the treatment of Achilles Tendonitis....

ORTHOReBIRTH USA received FDA 510(k) clearance to market ReBOSSIS® biosynthetic bone scaffold for use in posterolateral spine procedures....

FzioMed marked the worldwide sale of 500,000 units of its Oxiplex® viscoelastic hydrogel....

Anika Therapeutics received FDA 510(k) clearance to market a resorbable, injectable hyaluronic acid-based bone void filler....